Author:
Bai Jie,Zhao Shengyu,Fan Xiaoqing,Chen Yonghui,Zou Xiaowen,Hu Minwan,Wang Baolian,Jin Jing,Wang Xiaojian,Hu Jinping,Zhang Dan,Li Yan
Funder
State Key Laboratory of Bioactive Substance and Function of Natural Medicines
Institute of Materia Medica
Chinese Academy of Medical Sciences
Peking Union Medical College
Reference52 articles.
1. A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance;Advani;Clin. Cancer Res.,2001
2. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding;Aller;Science,2009
3. Biochemical, cellular, and pharmacological aspects of the multidrug transporter;Ambudkar;Annu. Rev. Pharmacol. Toxicol.,1999
4. The inhibitory effects of nobiletin on P-glycoprotein and the study of molecular mechanism;Bai;Acta Pharm. Sin.,2018
5. P-gp inhibition potential in cell-based models: which “calculation” method is the most accurate?;Balimane;AAPS J.,2008
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献